AJIC: American Journal of Infection Control
Volume 37, Issue 9 , Pages 773-777 , November 2009

The prevalence of multidose vial contamination by aerobic bacteria in a major teaching hospital, Shiraz, Iran, 2006

  • Mohammad Motamedifar, PhD

      Affiliations

    • Department of Bacteriology and Virology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
    • Corresponding Author InformationAddress correspondence to M. Motamedifar, PhD, Associate Professor of Microbiology, Department of Bacteriology and Virology, Shiraz Medical School, Shiraz University of Medical Sciences, P.O. Box 71455-119 Shiraz, Iran.
    • ,
  • Mehrdad Askarian, MD

      Affiliations

    • Department of Community Medicine, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran

References 

  1. Longfield RN, Smith LP, Longfield JN, Coberly J, Cruess D. Multiple-dose vials: persistence of bacterial contaminants and infection control implications. Infect Control. 1985;6:194–199
  2. Nakashima AK, Highsmith AK, Martone WJ. Survival of Serratia marcescens in benzalkonium chloride and in multiple-dose medication vials: relationship to epidemic septic arthritis. J Clin Microbiol. 1987;25:1019–1021
  3. Dade J, Wilcox M, Kay L. Hazards of multiple use of pharmaceutical solutions. Lancet. 2000;356:1684–1685
  4. Kirschke DL, Jones TF, Stratton CW, Barnett JA, Schaffner W. Outbreak of joint and soft-tissue infections associated with injections from a multiple-dose medication vial. Clin Infect Dis. 2003;36:1369–1373
  5. Melnyk PS, Shevchuk YM, Conly JM, Richardson CJ. Contamination study of multiple-dose vials. Ann Pharmacother. 1993;27:274–278
  6. Mattner F, Gastmeier P. Bacterial contamination of multiple-dose vials: a prevalence study. Am J Infect Control. 2004;32:12–16
  7. Moro ML, Maffei C, Manso E, Morace G, Polonelli L, Biavasco F. Nosocomial outbreak of systemic candidosis associated with parenteral nutrition. Infect Control Hosp Epidemiol. 1990;11:27–35
  8. Henry B, Plante-Jenkins C, Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control. 2001;29:312–315
  9. Plott RT, Wagner RF, Tyring SK. Iatrogenic contamination of multidose vials in simulated use: a reassessment of current patient injection technique. Arch Dermatol. 1990;126:1441–1444
  10. Stolar MH. Multiple-dose vials. Am J Hosp Pharm. 1980;37:185
  11. Askarian M, Hosseini RS, Kheirandish P, Assadian O. Incidence and outcome of nosocomial infections in female burn patients in Shiraz, Iran. Am J Infect Control. 2004;32:23–26
  12. Askarian M, Gooran NR. National nosocomial infection surveillance system-based study in Iran: additional hospital stay attributable to nosocomial infections. Am J Infect Control. 2003;31:465–468
  13. Magee L, Godsiff L, Matthews I, Farrington M, Park GR. Anaesthetic drugs and bacterial contamination. Eur J Anaesthesiol Suppl. 1995;12:41–43
  14. Taylor M, Bourke J, Anderson M. Titrated intravenous opioids from the same syringe: an infection risk?. J Accid Emerg Med. 1997;14:33–35
  15. Trautmann M, Zauser B, Wiedeck H, Buttenschön K, Marre R. Bacterial colonization and endotoxin contamination of intravenous infusion fluids. J Hosp Infect. 1997;37:225–236
  16. Bach A, Motsch J, Schmidt H, Böttiger BW, Böhrer H, Martin E, et al. In-use contamination of propofol: a clinical study. Eur J Anaesthesiol. 1997;14:178–183
  17. Bennett SN, McNeil MM, Bland LA, Arduino MJ, Villarino ME, Perrotta DM, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med. 1995;333:147–154
  18. Tresoldi AT, Padoveze MC, Trabasso P, Veiga JF, Marba ST, von Nowakonski A, et al. Enterobacter cloacae sepsis outbreak in a newborn unit caused by contaminated total parenteral nutrition solution. Am J Infect Control. 2000;28:258–261
  19. von Eiff C, Proctor RA, Peters G. Coagulase-negative staphylococci: pathogens have major role in nosocomial infections. Postgrad Med. 2001;110:63–76
  20. Tarr BD, Campbell RK, Workman TM. Stability and sterility ofbiosynthetic human insulin stored in plastic insulin syringes for 28 days. Am J Hosp Pharm. 1991;48:2631–2634
  21. Stetler HC, Garbe PL, Dwyer DM, Facklam RR, Orenstein WA, West GR, et al. Outbreaks of group A streptococcal abscesses following diphtheria-tetanus toxoid-pertussis vaccination. Pediatrics. 1985;75:299–303
  22. Bijma R, Girbes AR, Kleijer DJ, Zwaveling JH. Preventing central venous catheter-related infection in a surgical intensive-care unit. Infect Control Hosp Epidemiol. 1999;20:618–620
  23. Meier PA, Fredrickson M, Catney M, Nettleman MD. Impact of a dedicated intravenous therapy team on nosocomial bloodstream infection rates. Am J Infect Control. 1998;26:388–392
  24. Bawden JC, Jacobson JA, Jackson JC, Anderson RK, Burke JP. Sterility and use patterns of multiple-dose vials. Am J Hosp Pharm. 1982;39:294–297

 Supported by the Shiraz University of Medical Sciences grant No. 2398.

 Conflicts of interest: None to report.

PII: S0196-6553(09)00074-1

doi: 10.1016/j.ajic.2008.12.009

AJIC: American Journal of Infection Control
Volume 37, Issue 9 , Pages 773-777 , November 2009

Article Tools